Greenwood Shines Spotlight on Insurance Industry Rip-off
BIOtech Now Andrew Segerman Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a shocking Wall Street […]
Category: News
Using Biotechnology to Tackle Deadly Mosquito-Borne Illnesses
BIOtech Now Josh Falzone Every year, nearly a million deaths are attributed to mosquito-borne illnesses and 500 million people are infected with […]
Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innovation and Patient Access
BIOtech Now Andrew Segerman In October of 2018, the Trump Administration outlined a proposal that would import foreign price controls for medicines […]
The Right Way to Address Prescription Drug Costs
BIOtech Now Andrew Segerman Writing for STAT News, BIO’s President and CEO Jim Greenwood teamed up with Bay City Capital’s David Beier […]
BIO Illustrates the Success of the Orphan Drug Act
BIOtech Now Andrew Segerman The numbers might surprise you. Approximately 7,000 rare diseases are known to exist, and approximately 30 new ones […]
The Administration’s Orwellian Defense of Importing Foreign Price Controls
BIOtech Now Brian Newell The Trump administration is out with a new blog post defending its plan to adopt foreign price controls […]
Greenwood Talks Innovation, Drug Pricing, and the Midterm Elections on ForbesBooks Radio
BIOtech Now Andrew Segerman During the Forbes Healthcare Summit, BIO CEO Jim Greenwood joined Gregg Stebben, host of ForbesBooks Radio, for a […]
Greenwood: Think the Drug-Pricing debate addresses Patient Costs? Think again.
BIOtech Now Andrew Segerman Writing for The Hill, BIO President and CEO Jim Greenwood tackled the drug pricing debate in Washington and […]
Claims of Gene-Edited Twins Met with Criticism and Concern
BIOtech Now Andrew Segerman As the Second International Summit on Human Genome Editing wraps in Hong Kong this week, breaking news dominated much […]
Alzheimer’s Awareness Month: Hope on the Horizon
BIOtech Now Andrew Segerman Did you know that more than 5 million Americans are currently living with Alzheimer’s disease? If that number […]
Another Year, Another Misleading Insurance Company Report
BIOtech Now Brian Newell Once again, Blue Cross Blue Shield is out with a report attempting to stoke fear and confusion about […]
Survey Says: Solutions to Combat Against Antimicrobial Resistance Needed
BIOtech Now Andrew Segerman Writing for The Hill, Dr. Cynthia Sears, president of the Infectious Diseases Society of America (IDSA), discussed the […]
Patient and Health Advocacy Summit: Ensuring Patient Access and Affordability
BIOtech Now Andrew Segerman In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access to the medicines […]
BIO Patient & Health Advocacy Summit Concludes Today
BIOtech Now Theresa Brady Each year BIO brings the patient stakeholder community together for the BIO Patient and Health Advocacy Summit to […]
Patient Advocates Sounding the Alarm Over Fail First
BIOtech Now Andrew Segerman The Centers for Medicare & Medicaid Services (CMS) has reversed a long-standing policy allowing Medicare Advantage plans to […]
Making SMA Newborn Screening a Reality: Collaborating with the Patient Advocacy Community
BIOtech Now BIOtechNOW Editor Each year, roughly 12,500 newborns in the U.S., or one out of every 300 infants, are diagnosed with […]
Watchdog Report Reaffirms Concerns With Fail First
BIOtech Now Brian Newell A new report by the Office of Inspector General at the U.S. Department of Health and Human Services […]
2018 BIO Investor Forum Wraps Up
BIOtech Now Theresa Brady As the stock market continued its volatile swings this week, investors at the BIO Investor Forum—which wrapped up […]
World AMR Congress Keynote Panel to Explore Making “Pull” Incentives a Reality
BIOtech Now BIOtechNOW Editor Here’s a statistic you might not have known: an estimated 700,000 people die each year due to the […]
Drug Importation: Dangerous for Patients, Consumers, and American Communities
BIOtech Now Andrew Segerman Writing for The Hill, Steve Forbes, Forbes Media Chairman and Editor in Chief, delivered a simple message to […]